There is no universal rule that says a glass of wine during chemotherapy is flatly forbidden, but that does not mean it is harmless. The honest answer depends on which drugs you are receiving, how your liver is holding up, and what side effects you are already dealing with. A 2025 systematic review pooling data from thousands of patients found that moderate alcohol did not clearly worsen certain chemo toxicities, yet the same review flagged serious gaps in the evidence and cautioned that alcohol’s effect on treatment effectiveness has barely been studied. The reality is more layered than a simple yes or no, and the details matter.
Your Liver Is Already Working Overtime
The liver is ground zero for both alcohol processing and the metabolism of many chemotherapy agents. Alcohol is broken down primarily by enzymes in the liver, with an intermediate step that produces acetaldehyde, a toxic and potentially cancer-promoting byproduct.1PubMed Central. Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer Chemotherapy drugs are also processed through the liver, and several of them can cause direct liver injury on their own. Drugs like methotrexate, 5-fluorouracil (5-FU), and irinotecan are known to cause a form of liver damage sometimes called chemotherapy-induced steatohepatitis, which involves fatty buildup and inflammation in liver tissue.2PubMed Central. Chemotherapy-associated steatohepatitis
When you drink wine on top of a treatment regimen that already stresses the liver, you are asking the organ to handle two toxic loads at once. The liver enzyme CYP2E1, which plays a smaller role in alcohol breakdown under normal circumstances, becomes more active in people who drink regularly. This same enzyme is involved in activating certain chemotherapy drugs. The overlap creates a situation where alcohol could theoretically alter how quickly or slowly your body processes its chemo, though this interaction has not been pinned down with precision in human studies. The practical takeaway is straightforward: if your oncologist is already monitoring your liver enzymes because of your regimen, adding alcohol to the mix is not doing your liver any favors.
When Wine Could Directly Undermine Your Treatment
One of the more concrete concerns involves 5-fluorouracil, a chemotherapy drug used widely for cancers of the colon, stomach, breast, and head and neck. Research on oral squamous cell carcinoma tissue found that alcohol consumption correlated with higher activity of an enzyme called DPD, which is the main enzyme responsible for breaking down 5-FU in the body. Higher DPD activity means the drug gets degraded faster, leaving less of it available to do its job.3PubMed Central. Effects of smoking and alcohol consumption on 5-fluorouracil-related metabolic enzymes in oral squamous cell carcinoma In other words, drinking may reduce how well 5-FU works. This finding emerged from tissue-level analysis rather than a large clinical trial measuring patient outcomes, so it would be an overstatement to call it definitive. But if you are receiving a 5-FU-based regimen, this is exactly the kind of drug-specific risk worth discussing with your treatment team.
Beyond 5-FU, the evidence gets thinner. The 2025 systematic review and meta-analysis covering thousands of patients found no clear association between alcohol consumption and neurotoxicity in people receiving platinum-based or taxane-based chemotherapy.4PubMed Central. Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis That review also concluded that alcohol’s effect on the effectiveness of systemic therapies, including chemotherapy, targeted therapy, immunotherapy, and hormonal therapy, has simply not been studied enough to draw firm conclusions. So while the data on neurotoxicity is somewhat reassuring for certain drug classes, we genuinely do not know whether moderate drinking blunts treatment effectiveness across the board. The absence of evidence of harm is not the same as evidence of safety.
Alcohol and Nausea During Chemo
Here is one of the more counterintuitive findings. In pooled data from seven studies covering over 3,300 patients, people who drank alcohol actually had a lower risk of experiencing overall nausea during chemotherapy.4PubMed Central. Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis That might sound like a point in wine’s favor, but the picture is more nuanced than it first appears. The same analysis found no significant link between alcohol and acute or delayed nausea when those were measured separately. The “overall nausea” result may reflect something about who keeps drinking during treatment rather than a protective effect of alcohol itself. People who feel well enough to continue drinking may simply be the ones who were less nauseated to begin with. Researchers have noted this kind of selection effect in quality-of-life studies too: breast cancer survivors who reported better physical health were more likely to drink one to fourteen drinks per week, not because alcohol was making them healthier but because feeling physically well made them more inclined to drink.5Journal of Clinical Oncology. Association between alcohol intake and health-related quality of life in breast cancer survivors
It would be a mistake to look at this nausea data and decide that wine is a good anti-nausea strategy. The effect is modest, the direction of causation is unclear, and your oncologist has vastly better tools for managing chemo-related nausea, including modern anti-emetic drugs that have transformed the treatment experience over the past two decades.
The Gut Lining Takes a Double Hit
Chemotherapy, especially regimens involving 5-FU, can seriously damage the mucous membrane lining of the intestines. Animal research shows that 5-FU disrupts the protective mucus layer in the gut and degrades the tight junctions between intestinal cells, the molecular “seals” that keep the contents of your gut from leaking into your bloodstream.6PubMed Central. Muribaculum as a microbial contributor of rifaximin-induced mucosal protection during chemotherapy When that barrier breaks down, bacterial toxins can enter circulation and trigger widespread inflammation. This phenomenon, called mucositis in its clinical form, is behind many of the mouth sores, diarrhea, and gut pain that chemo patients experience.
Alcohol is independently irritating to the gut lining. It increases intestinal permeability on its own, and regular drinking shifts the composition of gut bacteria in ways that promote inflammation. Layering wine on top of a chemo-damaged gut means you are pouring an irritant onto tissue that is already compromised. For someone dealing with oral mucositis, even the acidity and alcohol content of wine can cause significant pain on contact. Patients who develop diarrhea or abdominal cramping during treatment would be wise to consider that alcohol may amplify these symptoms rather than alleviate them.
Nerve Damage Can Compound
Peripheral neuropathy, the tingling, numbness, or burning in your hands and feet, is one of the most common and persistent side effects of platinum-based drugs and taxanes. While the meta-analysis found no statistical link between alcohol consumption and this particular toxicity in over 3,000 patients, animal research tells a more concerning story. In a study of rats exposed to models of both chemotherapy-induced and alcohol-induced neuropathy, both conditions produced persistent pain sensitization in muscles and skin, and the damage progressed in parallel.7PubMed Central. Muscle pain in models of chemotherapy-induced and alcohol-induced peripheral neuropathy
The gap between the animal data and the human meta-analysis is worth acknowledging. It may be that the amounts of alcohol consumed by chemo patients in those pooled studies were modest enough not to register as a neuropathy risk factor. Heavy, chronic drinking is a well-established cause of peripheral neuropathy on its own, and it operates through some of the same nerve-damage pathways. If you are already experiencing numbness or tingling from treatment, adding a known nerve toxin, even in the form of a pleasant glass of wine, is probably not a risk worth taking. For someone with zero neuropathy symptoms on a regimen that does not typically cause them, the risk looks considerably smaller.
Some Chemo Drugs Already Contain Alcohol
This is something many patients do not realize until they are in the infusion chair. Several chemotherapy formulations use ethanol as a solvent to keep the drug dissolved and deliverable through an IV. Docetaxel is the most notable example. A multicenter study of 451 patients receiving docetaxel found that nearly half, about 44%, experienced ethanol-related symptoms during their infusions, including facial flushing, nausea, dizziness, and in a small number of cases, unsteady walking or impaired balance.8PubMed Central. A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy Female patients, younger patients, and those receiving higher docetaxel doses were more likely to experience these effects.
If your chemo infusion is already introducing alcohol into your bloodstream, drinking wine before or after a session adds to that load in ways you may not be accounting for. You could end up with a blood alcohol level higher than you expect, and the combination of infusion-related dizziness with a glass of wine afterward could affect your coordination or judgment, especially if you are driving yourself home from treatment. Always ask your pharmacist or nurse whether your specific regimen contains ethanol as a component.
Blood Cells and Bone Marrow Under Stress
Chemotherapy works by killing rapidly dividing cells, and blood-forming stem cells in the bone marrow are among the unintended targets. Low white blood cell counts, anemia, and easy bruising or bleeding are common consequences. Alcohol adds a separate layer of stress to this system. Acetaldehyde, the toxic intermediate produced when your body processes alcohol, is directly genotoxic to blood-forming stem cells. In the absence of adequate repair mechanisms, this damage can severely deplete the pool of cells that give rise to new blood cells.9PubMed Central. Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cells
For someone whose blood counts are already dangerously low from chemo, this is a real concern. Alcohol also suppresses immune cell function independently of its bone marrow effects. If your oncologist has flagged low neutrophil counts (the immune cells that fight bacterial infections) or your platelet counts are dropping, layering wine on top of those deficits is risky. On the other hand, someone mid-treatment whose counts are holding steady and who is otherwise tolerating treatment well faces a different risk calculus than someone in a nadir, the low point of blood counts between cycles.
Breast Cancer, Hormones, and Wine
For women with hormone-receptor-positive breast cancer, the question of wine carries a specific wrinkle beyond general chemo concerns. Many of these patients take aromatase inhibitors, drugs that work by suppressing estrogen production, sometimes for five years or more. Alcohol is known to raise estrogen levels in postmenopausal women, which could theoretically counteract the very purpose of these medications. A pilot study specifically designed to investigate this looked at sex hormone levels in postmenopausal breast cancer survivors taking aromatase inhibitors after they consumed white wine versus white grape juice, and the question of whether one daily serving of alcohol raises hormone levels enough to matter in this population remains unanswered.10PubMed Central. Effect of daily alcohol intake on sex hormone levels among postmenopausal breast cancer survivors on aromatase inhibitor therapy: a randomized controlled crossover pilot study
This is an area where the science is genuinely unsettled, and it is worth being honest about that. The epidemiological data linking alcohol to breast cancer risk in the first place is strong. Whether continuing to drink after a diagnosis and during treatment worsens outcomes is a separate question, and large randomized trials addressing it do not exist. Many breast cancer patients choose to stop drinking entirely out of an abundance of caution, and that is a reasonable decision given the hormonal biology involved.
How Many Cancer Patients Actually Drink During Treatment
If you are a cancer patient wondering about this, you are far from alone. A large analysis using data from the All of Us Research Program found that among cancer survivors actively receiving treatment, over three-quarters were current drinkers. Among those drinkers, roughly one in eight exceeded what is considered moderate intake, about a quarter reported binge drinking episodes, and nearly 40% met criteria for what researchers classify as hazardous drinking.11PubMed Central. Alcohol Consumption Among Adults With a Cancer Diagnosis in the All of Us Research Program These rates were similar regardless of the type of cancer treatment people were receiving.
What makes these numbers striking is the disconnect between how many patients drink and how little guidance most of them receive. A study comparing palliative and curative cancer patients found that patients who had been counseled about alcohol by their healthcare providers were roughly twice as likely to perceive continued drinking as harmful to their fatigue levels compared to those who had received no counseling.12Journal of Clinical Oncology. Palliative versus nonpalliative patients’ perceptions of the effect of alcohol consumption on clinical outcomes The fact that such a basic conversation changes patient perceptions so dramatically suggests that many oncology teams simply do not bring it up, leaving patients to guess.
What About Resveratrol
Red wine enthusiasts sometimes point to resveratrol, the polyphenol found in grape skins, as a reason wine might even be beneficial during treatment. There is a kernel of interesting science here: in an animal model, resveratrol reduced markers of kidney damage caused by chemotherapy, lowering measures of oxidative stress and preserving more normal kidney structure compared to chemo alone.13Khyber Medical University Journal. RESVERATROL ATTENUATES OXIDATIVE STRESS IN CHEMOTHERAPY INDUCED ACUTE KIDNEY INJURY: AN EXPERIMENTAL RAT MODEL But this was resveratrol administered as an isolated compound to rats, not humans sipping Pinot Noir. The amount of resveratrol in a glass of red wine is tiny compared to the doses used in laboratory experiments, and any hypothetical benefit from the resveratrol would be delivered alongside ethanol and acetaldehyde, which have their own damaging effects. Drinking wine for the resveratrol during chemo is a bit like eating a candy bar for the antioxidants in the cocoa.
Practical Questions for Your Oncologist
If you want to have an informed conversation with your treatment team about wine during chemo, there are specific things worth asking about rather than posing the question in the abstract. First, ask whether any of your drugs are metabolized through pathways that overlap with alcohol, especially if your regimen includes 5-FU or related compounds. Second, ask about the ethanol content of your infusion formulations, since some patients are surprised to learn they are already receiving alcohol intravenously. Third, ask about the current state of your liver function tests and blood counts. If both are in acceptable ranges and your side effects are manageable, the conversation looks different than if your liver enzymes are elevated or your white count is borderline. Fourth, if you have hormone-receptor-positive breast cancer and are on an aromatase inhibitor, ask specifically about the estrogen question.
Timing also matters in ways that are easy to overlook. Most chemo patients cycle through phases of feeling relatively okay and phases of feeling terrible. Drinking during the nadir, typically seven to fourteen days after an infusion when blood counts bottom out, carries substantially more risk than having a glass of wine a day or two before your next cycle when your body has had time to recover. Some oncologists informally advise patients that if they are going to drink at all, doing so in the days immediately before a cycle rather than immediately after is the lower-risk choice, though this is not a formal guideline.
Alcohol interacts differently with anti-nausea medications, pain medications, and sleep aids that many chemo patients rely on. Benzodiazepines, opioids, and even over-the-counter sleep supplements all have their sedative effects amplified by alcohol. If you are taking any of these as part of your supportive care regimen, a single glass of wine could hit you much harder than it normally would, raising the risk of falls, confusion, and excessive sedation.